Warren Buffett is satisfied with his IBM holdings, but is Jim Cramer satisfied with the stock? Not exactly. ‘Warren Buffett is addicted to buybacks and dividends. I want more than that. They have to make acquisitions,’ said Cramer, portfolio manager of TheStreet’s Action Alerts PLUS and host of CNBC’s ‘Mad Money’. Cramer suggested that IBM buy ClickSoftware Technologies (CKSW) and CyberArk (CYBR). Cramer made the comments while answering viewers’ questions from social media from the floor of the New York Stock Exchange Tuesday. Cramer also discussed a number of healthcare and biotechnology stocks, saying that investors should buy Allergan (AGN), Biogen (BIB), Gilead (GILD). Cramer also said he prefers Allegan over Valeant (VRX) and said he’s staying away from Amicus Therapeutics (FOLD) and almost all of the small biotech companies, which he said are under year-end selling pressure. Send your questions to Jim Cramer on his Facebook page or on Twitter @jimcramer, using #CramerQ.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
